| | Gesundheitswissenschaften > | AGB-Behandlungen | Neurologische Erkrankungen

Parkinson's Disease Life Expectancy: Key Factors Influencing Survival

Parkinson's disease (PD) is a progressive neurodegenerative disorder. While it shortens life expectancy modestly, many live decades with good quality of life.

Survival Data

Median survival from diagnosis: 10–15 years (highly variable).
Median age at death: ~80–85 years (vs. ~82 general population).
Standardized mortality ratio: 1.5–2.5× general population.

Key Prognostic Factors

Factor	Association with Survival
Younger onset (<50)	Longer absolute survival but more years with disability
Older onset (>70)	Shorter survival; faster progression
Motor phenotype: tremor‑dominant	Better prognosis vs. PIGD (postural instability/gait difficulty)
Cognitive impairment/dementia	Strongest predictor of mortality
Comorbidities (CVD, diabetes)	Reduce survival independently
Orthostatic hypotension, dysphagia	Markers of advanced autonomic/bulbar involvement

Management Impact

Levodopa and dopaminergic therapy improve function but do not demonstrably alter disease progression.
Deep brain stimulation (DBS) improves motor complications, quality of life.
Multidisciplinary care (PT, OT, SLP, neuropsychology, palliative) optimizes independence.
Fall prevention, aspiration precautions, and advance care planning are critical in advanced stages.

Message to Patients

PD is a marathon, not a sprint. Proactive, individualized care enables many to live fulfilling lives for years after diagnosis. Focus on function and quality of life, not just survival statistics.

Neurologische Erkrankungen

Gesundheitswissenschaften